Mr. Speaker, I am rising on a point of order.
There have been discussions, and I hope that, if you seek it, you will find unanimous consent for the following motion that, in the opinion of the House, the government should do more to address global vaccine equity by sharing resources, doses and knowledge, by taking the following actions: (a) announcing its full support for a temporary waiver of the agreement on trade-related aspects of intellectual property rights, the TRIPS agreement, in relation to products and technologies related to the prevention, treatment or containment of COVID-19 as proposed by India and South Africa to the World Trade Organization; (b) facilitating the transfer of technology to manufacture COVID-19 vaccines around the world, including financial support for regional hubs such as the South Africa technology transfer hub; (c) following through on its own claims of the effectiveness of Canada's access to medicines regime, CAMR, by taking the necessary steps of adding COVID-19 vaccines and drugs to schedule 1 of the Patent Act; (d) donating at least 200 million doses of vaccine as promised to vulnerable populations around the world through COVAX by the end of 2022, through predictable and scheduled donations where timelines and quantities are transparently available to recipient countries and the public; (e) increasing assistance with cold chain logistics and supplies to low-income countries receiving vaccines; (f) delivering at least an additional $1.1 billion as a net addition to the international assistance envelope and existing departmental resources to address global vaccine equity in budget 2022, including $780 million to ACT-Accelerator partners to purchase vaccines, tests, treatments, personal protective equipment and oxygen in developing countries and—